Applied Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Applied Therapeutics
APLT Stock  USD 0.10  0  2.99%   
Analyzing historical trends in various income statement and balance sheet accounts from Applied Therapeutics' financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Applied Therapeutics' valuation are summarized below:
Gross Profit
-38.1 M
Market Capitalization
14 M
Enterprise Value Revenue
5.7066
Revenue
1000 K
Earnings Share
(0.10)
There are currently one hundred twenty fundamental signals for Applied Therapeutics that can be evaluated and compared over time across rivals. All traders should validate Applied Therapeutics' prevailing fundamentals against the performance from 2010 to 2026 and make sure the trends continue to evolve in the right direction.

Applied Therapeutics Total Revenue

432,250

Check Applied Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Applied Therapeutics' main balance sheet or income statement drivers, such as Net Interest Income of 3.7 M, Interest Income of 3.7 M or Discontinued Operations of 0.0, as well as many indicators such as Price To Sales Ratio of 276, Dividend Yield of 0.0 or PTB Ratio of 2.2. Applied financial statements analysis is a perfect complement when working with Applied Therapeutics Valuation or Volatility modules.
  
Build AI portfolio with Applied Stock
Check out the analysis of Applied Therapeutics Correlation against competitors.
For more information on how to buy Applied Stock please use our How to Invest in Applied Therapeutics guide.

Applied Therapeutics Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets61.4 M86.7 M33.2 M
Slightly volatile
Other Current Liabilities21.9 M22.2 M11.5 M
Slightly volatile
Total Current Liabilities27.4 M27.3 M14.6 M
Slightly volatile
Accounts Payable4.6 M4.4 M2.7 M
Slightly volatile
Cash41 M79.4 M22.6 M
Slightly volatile
Cash And Short Term Investments54.8 M79.4 M29.8 M
Slightly volatile
Common Stock Shares Outstanding146.5 M139.5 M34.4 M
Slightly volatile
Liabilities And Stockholders Equity61.4 M86.7 M33.2 M
Slightly volatile
Capital Surpluse293.2 M279.2 M103.2 M
Slightly volatile
Other Current Assets4.6 M4.2 M2.4 M
Slightly volatile
Total Liabilities29.3 M29.7 M18.3 M
Slightly volatile
Total Current Assets60 M83.6 M32.4 M
Slightly volatile
Short and Long Term Debt Total1.7 M2.8 M2 M
Very volatile
Property Plant And Equipment Net2.9 M2.8 M1.9 M
Very volatile
Current Deferred Revenue201.4 K212 K5.2 M
Very volatile
Capital Lease Obligations2.9 M2.8 M1.9 M
Pretty Stable
Property Plant And Equipment Gross2.9 M2.8 M1.9 M
Very volatile
Net Receivables318 K256.5 K450.9 K
Slightly volatile
Non Current Liabilities Other681.3 K683.1 K1.1 M
Slightly volatile

Applied Therapeutics Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Interest Income3.7 M3.5 M848.2 K
Slightly volatile
Depreciation And Amortization8559003.1 M
Slightly volatile
Selling General Administrative58.2 M55.5 M16 M
Slightly volatile
Other Operating Expenses72.3 M104.8 M39.2 M
Slightly volatile
Research Development45.4 M48.7 M25.1 M
Slightly volatile
Total Operating Expenses58.1 M56 M31.9 M
Slightly volatile
Reconciled Depreciation374.2 K426 K163.9 K
Slightly volatile
Selling And Marketing Expenses562.6 K549 K499 K
Slightly volatile

Applied Therapeutics Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation7.7 M13.5 M4 M
Slightly volatile
Begin Period Cash Flow30.1 M49.9 M15.6 M
Slightly volatile
Other Cashflows From Financing Activities6 M9.4 M7 M
Very volatile
Depreciation286.8 K425 K158.4 K
Slightly volatile
Total Cash From Financing Activities71 M113.8 M39.6 M
Slightly volatile
End Period Cash Flow41 M79.4 M22.6 M
Slightly volatile
Change To Netincome6.8 M12.4 M4.7 M
Slightly volatile
Issuance Of Capital Stock76.3 M104.7 M45.7 M
Slightly volatile
Cash And Cash Equivalents Changes30.9 M34.8 M37.9 M
Slightly volatile
Cash Flows Other Operating1.2 M1.4 M1.5 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio27626358.3533
Slightly volatile
Days Sales Outstanding8.339.3710.2148
Slightly volatile
Stock Based Compensation To Revenue31.0829.59784.4368
Slightly volatile
EV To Sales98.9294.212932.481
Slightly volatile
Payables Turnover0.110.09730.4369
Slightly volatile
Sales General And Administrative To Revenue12912317.5776
Slightly volatile
Research And Ddevelopement To Revenue11210718.4462
Slightly volatile
Cash Per Share0.540.5691.1257
Slightly volatile
Days Payables Outstanding3.4 K3.4 K1.8 K
Slightly volatile
Income Quality0.840.79820.7613
Pretty Stable
Current Ratio3.333.06443.1728
Slightly volatile
Receivables Turnover28.0531.5634.4059
Slightly volatile
Revenue Per Share0.00310.00330.1042
Slightly volatile
Interest Debt Per Share0.0190.020.1263
Slightly volatile
Debt To Assets0.0350.03220.0378
Slightly volatile
Days Of Payables Outstanding3.4 K3.4 K1.8 K
Slightly volatile
Ebt Per Ebit0.91.01271.0608
Pretty Stable
Long Term Debt To Capitalization0.09690.09230.0571
Slightly volatile
Quick Ratio3.333.06443.1727
Slightly volatile
Cash Ratio2.442.90882.7039
Slightly volatile
Days Of Sales Outstanding8.339.3710.2148
Slightly volatile
Fixed Asset Turnover0.150.16319.5808
Slightly volatile
Debt Ratio0.0350.03220.0378
Slightly volatile
Price Sales Ratio27626358.3533
Slightly volatile
Asset Turnover0.0050.00520.1601
Slightly volatile

Applied Therapeutics Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap391.9 M263.5 M416.3 M
Slightly volatile
Enterprise Value333.4 M203.9 M361.6 M
Slightly volatile

Applied Fundamental Market Drivers

Applied Upcoming Events

28th of March 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View

About Applied Therapeutics Financial Statements

Applied Therapeutics shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Applied Therapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in Applied Therapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Applied Therapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue212 K201.4 K
Total Revenue455 K432.2 K
Cost Of Revenue48.7 M51.2 M
Stock Based Compensation To Revenue 29.60  31.08 
Sales General And Administrative To Revenue 123.10  129.25 
Research And Ddevelopement To Revenue 107.13  112.49 
Ebit Per Revenue(229.23)(240.69)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Applied Stock Analysis

When running Applied Therapeutics' price analysis, check to measure Applied Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Applied Therapeutics is operating at the current time. Most of Applied Therapeutics' value examination focuses on studying past and present price action to predict the probability of Applied Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Applied Therapeutics' price. Additionally, you may evaluate how the addition of Applied Therapeutics to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2025 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY